PRECREST: a phase II prevention and biomarker trial of creatine in at-risk Huntington disease.
Rosas HD, Doros G, Gevorkian S, Malarick K, Reuter M, Coutu JP, Triggs TD, Wilkens PJ, Matson W, Salat DH, Hersch SM.
Rosas HD, et al. Among authors: coutu jp.
Neurology. 2014 Mar 11;82(10):850-7. doi: 10.1212/WNL.0000000000000187. Epub 2014 Feb 7.
Neurology. 2014.
PMID: 24510496
Free PMC article.
Clinical Trial.